Durability of rilpivirine- versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy
- Gagliardini, Roberta
- Gianotti, Nicola
- Maggiolo, Franco
- Cozzi-Lepri, Alessandro
- Antinori, Andrea
- Nozza, Silvia
- Lapadula, Giuseppe
- De Luca, Andrea
- Mussini, Cristina
- Gori, Andrea
- Saracino, Annalisa
- Andreoni, Massimo
- Monforte
- Antonella d'Arminio
- Luchino Chessa
- in Icona Fondation Study Group.
Publication date
January 2021
DOIAbstract
Comparisons between rilpivirine (RPV) and integrase strand transfer inhibitors (INSTIs) in antiretroviral therapy (ART)-naïve HIV-infected individuals are currently lacking. Aim of the study was to compare, in an observational cohort setting, the durability of treatment of RPV- and INSTI-based first-line regimens
Add to ORKG